Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

The following Interfaces are supported For financial accounting, the following interfaces provided as RESTful-API show results for deal 001-FK_LN–Consumer-Annuity). To expand please click on the specific line.

...

Expand
titleGET /loans/debit-credit-entries (001-FK_LN-A-Consumer-Annuity)

GET /loans/debit-credit-entries (001-FK_LN-A-Consumer-Annuity)

The following table shows for for  a specific

  • tenant (companyId) and
for
  • deal (dealId) "001-FK_LN-A-Consumer-Annuity" and 
  • IFRS accounting rules (gaap)

the expected debit/credit entries considering IFRS accounting rules (gaap) at  at various posting dates (postingDate)

For the explanation of data fields see here.

For an explanation of the accounting logic regarding different accounting event types refer to Loan: Examples of set of entries.


postingDate validityDateaccountingEventTypesetOfEntriesbookingSortNo debitCreditSign
genledAccountNumber
 genledAccountNumber
 genledAccountName-
genledAccountNamesignOfMeasureOrRatiomeasureOrRatioDescriptionamountOriginalcurrencyOriginalamountbal
13/09/201813/09/2018IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)
D
-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.247.45
214.04
EUR
214
247.
04
45
13/09/201813/09/2018IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)
C
-
247.45175.9
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.247.45EUR
175
247.
9
45
14/09/201814/09/2018CASHFLOWLN A Capital Payout Contractual10D10622000001Loan Sub-Acc. Principal Amount
D
-
-
Capital amount0
175.9
EUR
175.9
0
14/09/201814/09/2018CASHFLOWLN A Capital Payout Contractual20C10622000014Loan Sub-Acc. Daily payable (Principal)
C
-
-
Capital amount0
2.96
EUR
2.96
0
14/09/201814/09/2018CASHFLOWLN A Capital Payout Contractual10D10622000001Loan Sub-Acc. Principal Amount
D
-
-
Capital amount33000
2.96
EUR
2.96
33000
14/09/201814/09/2018CASHFLOWLN A Capital Payout Contractual20C10622000014Loan Sub-Acc. Daily payable (Principal)
C
-
-
Capital amount33000
229.79
EUR
229.79
33000
14/09/201814/09/2018CASHFLOWLN A Capital Payout Real Payment10D10622000014Loan Sub-Acc. Daily payable (Principal)
D
-
-
Capital amount33000
229.79
EUR
229.79
33000
14/09/201814/09/2018CASHFLOWLN A Capital Payout Real Payment20C39991000001Settlement Account
C
-
-
Capital amount33000
175.9
EUR
175.9+
33000
14/09/201814/09/2018IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)
D
+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.247.45
175.9
EUR
175
247.
9+
45
14/09/201814/09/2018IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)
C
+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.247.45
2.96
EUR
2
247.
96-
45
14/09/201814/09/2018IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)
D
-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.247.5
2.81
EUR
2
247.
81-
5
14/09/201814/09/2018IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)
C
-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.247.5
2.96
EUR
2
247.
96
5
30/09/201817/09/2018IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)
D
+
247.52.81
Difference between contractual and effective interest rate excl. amortisation1.76EUR
2
1.
81
76
30/09/201817/09/2018IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)
C
+
247.5837.91
Difference between contractual and effective interest rate excl. amortisation1.76EUR
837
1.
91
76
30/09/201830/09/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears50D40153000002LN Interest Smoothing Effect
D
-
1.76837.91
Accrual/deferral of interest112.93EUR
837
112.
91
93
30/09/201830/09/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears60C10622000008Loan Sub-Acc. Interest Portions to be amortised
C
-
1.76837.91
Accrual/deferral of interest112.93EUR
837
112.
91
93
30/09/201830/09/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral
D
+
112.93837.91
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.247.5EUR
837
247.
91
5
30/09/201830/09/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income
C
+
112.93222.18
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.247.5EUR
222
247.
18
5
30/09/201830/09/2018IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)
D
-
248.33222.18
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.248.33EUR
222
248.
18-
33
30/09/201830/09/2018IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)
C
-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.248.33
229.79
EUR
229
248.
79
33
31/12/201801/10/2018CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account
D229.79
+
906.85
Difference between contractual and effective interest rate excl. amortisation1.76EUR
229
1.
79
76
31/12/201801/10/2018CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)
C
+
906.85188.93
Difference between contractual and effective interest rate excl. amortisation1.76EUR
188
1.
93
76
31/12/201801/10/2018CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)
D
+
906.85188
Accrual/deferral of interest112.93EUR
188
112.93
31/12/201801/10/2018CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount
C
+
906.85188
Accrual/deferral of interest112.93EUR
188
112.93
31/12/201801/10/2018CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)
D
+
119.99188.93
Accrual/deferral of interest175.9EUR
188
175.
93
9
31/12/201801/10/2018CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income
C
+
119.992.81
Accrual/deferral of interest175.9EUR
2
175.
81
9
31/12/201801/10/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account
D
+
119.99
Difference between contractual and effective interest rate excl. amortisation2.
81
96EUR2.
81
96
31/12/201801/10/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)
C
+
119.99222.18
Difference between contractual and effective interest rate excl. amortisation2.96EUR
222
2.
18
96
31/12/201801/10/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears50C40153000002LN Interest Smoothing Effect
C
-
1.76222.18
Capital amount812.8EUR
222
812.
18
8
31/12/201801/10/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears60D10622000008Loan Sub-Acc. Interest Portions to be amortised
D
-
1.76177.4
Capital amount812.8EUR
177
812.
4
8
31/12/201801/10/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10C10622000002Loan Sub-Acc. Interest Accrual/Deferral
C
+
112.93177.4
Capital amount820.91EUR
177
820.
4
91
31/12/201801/10/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20D40153000001LN Interest Income
D
+
112.936.55
Capital amount820.91EUR
6
820.
55
91
31/12/201801/10/2018IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)
D
+
248.336.55
Capital amount906.85EUR
6
906.
55
85
31/12/201801/10/2018IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)
C
+
248.33223.54
Capital amount906.85EUR
223
906.
54
85
31/12/201801/11/2018CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account
D
+
820.91223.54
Capital amount812.8EUR
223
812.
54
8
31/12/201801/11/2018CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)
C
+
820.91177.4
Capital amount812.8EUR
177
812.
4
8
31/12/201801/11/2018CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)
D
+
+
Capital amount820.91
177.4
EUR
177
820.
4
91
31/12/201801/11/2018CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount
C
+
+
Capital amount820.91
6.55
EUR
6
820.
55
91
31/12/201801/11/2018CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)
D
+
205.936.55
Capital amount906.85EUR
6
906.
55
85
31/12/201801/11/2018CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income
C
+
205.93843.1
Capital amount906.85EUR
843
906.
1
85
31/12/201801/11/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account
D
+
205.93843.1
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.229.79EUR
843
229.
1
79
31/12/201801/11/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)
C
+
205.93843.1
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.229.79EUR
843
229.
1
79
31/12/201803/12/2018CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account
D
+
812.8843.1
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.248.33EUR
843
248.
1
33
31/12/201803/12/2018CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)
C
+
812.8223.54
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.248.33EUR
223
248.
54
33
31/12/201803/12/2018CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)
D
+
812.8223.54
Capital amount119.99EUR
223
119.
54
99
31/12/201803/12/2018CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount
C
+
812.8183.74
Capital amount119.99EUR
183
119.
74
99
31/12/201803/12/2018CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)
D
+
214.04183.74
Capital amount205.93EUR
183
205.
74
93
31/12/201803/12/2018CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income
C
+
214.04183.74
Capital amount205.93EUR
183
205.
74
93
31/12/201803/12/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account
D
+
+
Capital amount214.04
183.74
EUR
183
214.
74
04
31/12/201803/12/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)
C
+
+
Capital amount214.04
842.18
EUR
842
214.
18
04
31/12/201831/12/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral
D
+
175.9842.18
Capital amount119.99EUR
842
119.
18
99
31/12/201831/12/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income
C
+
175.9842.18
Capital amount119.99EUR
842
119.
18
99
31/12/201831/12/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears30D10622000008Loan Sub-Acc. Interest Portions to be amortised
D
+
2.96842.18
Capital amount205.93EUR
842
205.
18
93
31/12/201831/12/2018
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears40C40153000002LN Interest Smoothing Effect
C
+
2.96184.66
Capital amount205.93EUR
184
205.
66
93
31/12/201831/12/2018IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)
D
-
229.79184.66
Capital amount214.04EUR
184
214.
66
04
31/12/201831/12/2018IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)
C
-
229.79184.66
Capital amount214.04EUR
184
214.
66
04
02/01/201902/01/2019CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account
D
+
837.91184.66
Accrual/deferral of interest175.9EUR
184
175.
66
9
02/01/201902/01/2019CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)
C
+
837.91113.53
Accrual/deferral of interest175.9EUR
113
175.
53
9
02/01/201902/01/2019CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)
D
+
837.91113.53
Difference between contractual and effective interest rate excl. amortisation2.81EUR
113
2.
53
81
02/01/201902/01/2019CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount
C10.02
+
837.91
Difference between contractual and effective interest rate excl. amortisation2.81EUR
10
2.
02
81
02/01/201902/01/2019CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)
D10.02
+
188.93
Difference between contractual and effective interest rate excl. amortisation2.96EUR
10
2.
02
96
02/01/201902/01/2019CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income
C210.3
+
188.93
Difference between contractual and effective interest rate excl. amortisation2.96EUR
210
2.
3
96
02/01/201902/01/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account
D210.3
+
188.93
Capital amount837.91EUR
210
837.
3
91
02/01/201902/01/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)
C
+
188.93113.53
Capital amount837.91EUR
113
837.
53
91
02/01/201902/01/2019IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)
D
-
222.18113.53
Capital amount837.91EUR
113
837.
53
91
02/01/201902/01/2019IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)
C10.02
-
222.18
Capital amount837.91EUR
10
837.
02
91
02/01/201902/01/2019IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)
D10.02
+
229.79
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.222.18EUR
10
222.
02
18
02/01/201902/01/2019IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)
C
+
229.79210.3
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.222.18EUR
210
222.
3
18
02/01/201902/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10C10622000002Loan Sub-Acc. Interest Accrual/Deferral
C210.3
+
175.9
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.229.79EUR
210
229.
3
79
02/01/201902/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20D40153000001LN Interest Income
D
+
175.9173.28
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.229.79EUR
173
229.
28
79
02/01/201902/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears30D10622000008Loan Sub-Acc. Interest Portions to be amortised
D
+
2.81173.28
Capital amount188.93EUR
173
188.
28
93
02/01/201902/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears40C40153000002LN Interest Smoothing Effect
C
+
2.814.87
Capital amount188.93EUR
4
188.
87
93
02/01/201902/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears30C10622000008Loan Sub-Acc. Interest Portions to be amortised
C
+
2.964.87
Capital amount188.93EUR
4
188.
87
93
02/01/201902/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears40D40153000002LN Interest Smoothing Effect
D210.79
+
2.96
Capital amount188.93EUR
210
188.
79
93
31/01/201903/01/2019IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)
D210.79
+
222.18
Accrual/deferral of interest177.4EUR
210
177.
79
4
31/01/201903/01/2019IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)
C
+
222.18223.54
Accrual/deferral of interest177.4EUR
223
177.
54
4
31/01/201903/01/2019
Distribution of Payment in Arrears+

DISTR ARR

LN A Accrual Incoming Interest in Arrears30C10622000008Loan Sub-Acc. Interest Portions to be amortised
C
+Difference between contractual and effective interest rate excl. amortisation2.81
6.55
EUR
6
2.
55
81
31/01/201903/01/2019
Distribution of Payment in Arrears+

DISTR ARR

LN A Accrual Incoming Interest in Arrears40D40153000002LN Interest Smoothing Effect
D
+Difference between contractual and effective interest rate excl. amortisation2.81
6.55
EUR
6
2.
55
81
31/01/201931/01/2019IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)
D
-
223.54177.4
Difference between contractual and effective interest rate excl. amortisation6.55EUR
177
6.
4
55
31/01/201931/01/2019IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)
C
-
223.54177.4
Difference between contractual and effective interest rate excl. amortisation6.55EUR
177
6.
4
55
31/01/201931/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral
D
+
177.42.81
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.222.18EUR
2
222.
81
18
31/01/201931/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income
C
+
177.42.81
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.222.18EUR
2
222.
81
18
31/01/201931/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears30D10622000008Loan Sub-Acc. Interest Portions to be amortised
D+6.55222.18
+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.223.54EUR
222
223.
18
54
31/01/201931/01/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears40C40153000002LN Interest Smoothing Effect
C
+
6.55222.18
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.223.54EUR
222
223.
18
54
20/03/201901/02/2019CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account
D
+
843.16.55
Difference between contractual and effective interest rate excl. amortisation10.02EUR
6
10.
55
02
20/03/201901/02/2019CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)
C
+
843.16.55
Difference between contractual and effective interest rate excl. amortisation10.02EUR
6
10.
55
02
20/03/201901/02/2019CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)
D
+
843.1177.4
Accrual/deferral of interest113.53EUR
177
113.
4
53
20/03/201901/02/2019CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount
C
+
843.1177.4
Accrual/deferral of interest113.53EUR
177
113.
4
53
20/03/201901/02/2019CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)
D
+
183.74843.1
Accrual/deferral of interest177.4EUR
843
177.
1
4
20/03/201901/02/2019CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income
C
+
183.74843.1
Accrual/deferral of interest177.4EUR
843
177.
1
4
20/03/201901/02/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account
D
+
183.74842.18
Difference between contractual and effective interest rate excl. amortisation6.55EUR
842
6.
18
55
20/03/201901/02/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)
C
+
183.74842.18
Difference between contractual and effective interest rate excl. amortisation6.55EUR
842
6.
18
55
20/03/201901/02/2019IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)
D
+
223.54183.74
Capital amount842.18EUR
183
842.
74
18
20/03/201901/02/2019IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)
C
+
223.54183.74
Capital amount842.18EUR
183
842.
74
18
20/03/201901/02/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10C10622000002Loan Sub-Acc. Interest Accrual/Deferral
C
+
177.4184.66
Capital amount843.1EUR
184
843.
66
1
20/03/201901/02/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20D40153000001LN Interest Income
D
+
177.4184.66
Capital amount843.1EUR
184
843.
66
1
20/03/201901/02/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears30C10622000008Loan Sub-Acc. Interest Portions to be amortised
C
+
6.55843.1
Capital amount842.18EUR
843
842.
1
18
20/03/201901/02/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears40D40153000002LN Interest Smoothing Effect
D
+
6.55843.1
Capital amount842.18EUR
843
842.
1
18
20/03/201901/03/2019CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account
D
+
842.18183.74
Capital amount843.1EUR
183
843.
74
1
20/03/201901/03/2019CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)
C
+
842.18183.74
Capital amount843.1EUR
183
843.
74
1
20/03/201901/03/2019CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)
D
+
842.18842.18
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.210.3EUR
842
210.
18
3
20/03/201901/03/2019CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount
C
+
842.18842.18
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.210.3EUR
842
210.
18
3
20/03/201901/03/2019CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)
D
+
184.66184.66
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.223.54EUR
184
223.
66
54
20/03/201901/03/2019CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income
C
+
184.66184.66
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.223.54EUR
184
223.
66
54
20/03/201901/03/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account
D
+
184.66223.54
Capital amount183.74EUR
223
183.
54
74
20/03/201901/03/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments
20
20C10622000015Loan Sub-Acc. Daily payable (Interest)
C
+
184.66223.54
Capital amount183.74EUR
223
183.
54
74
20/03/201920/03/2019IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)
D
-
210.3210.3
Capital amount184.66EUR
210
184.
3
66
20/03/201920/03/2019IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)
C210.3
-
210.3
Capital amount184.66EUR
210
184.
3
66
20/03/201920/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears50D40153000002LN Interest Smoothing Effect
D10.02
-
10.02
Capital amount183.74EUR
10
183.
02
74
20/03/201920/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears60C10622000008Loan Sub-Acc. Interest Portions to be amortised
C
-
10.0210.02
Capital amount183.74EUR
10
183.
02
74
20/03/201920/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral
D
+
113.53113.53
Capital amount184.66EUR
113
184.
53
66
20/03/201920/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income
C
+
113.53113.53
Capital amount184.66EUR
113
184.
53
66
31/03/201921/03/2019IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)
D
+
210.34.87
Difference between contractual and effective interest rate excl. amortisation10.02EUR
4
10.
87
02
31/03/201921/03/2019IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)
C
+
210.34.87
Difference between contractual and effective interest rate excl. amortisation10.02EUR
4
10.
87
02
31/03/201921/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears50C40153000002LN Interest Smoothing Effect
C
-
10.02173.28
Accrual/deferral of interest113.53EUR
173
113.
28
53
31/03/201921/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears60D10622000008Loan Sub-Acc. Interest Portions to be amortised
D
-
10.02173.28
Accrual/deferral of interest113.53EUR
173
113.
28
53
31/03/201921/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10C10622000002Loan Sub-Acc. Interest Accrual/Deferral
C10.02
+
113.53
Accrual/deferral of interest173.28EUR
10
173.
02
28
31/03/201921/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20D40153000001LN Interest Income
D10.02
+
113.53
Accrual/deferral of interest173.28EUR
10
173.
02
28
31/03/201931/03/2019IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)
D
-
210.79113.53
Difference between contractual and effective interest rate excl. amortisation4.87EUR
113
4.
53
87
31/03/201931/03/2019IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)
C
-
210.79113.53
Difference between contractual and effective interest rate excl. amortisation4.87EUR
113
4.
53
87
31/03/201931/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral
D
+
173.28
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.210.
79
3EUR210.
79
3
31/03/201931/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income
C
+
173.28
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.210.
79
3EUR210.
79
3
31/03/201931/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears50D40153000002LN Interest Smoothing Effect
D
-
4.87
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.210.
3
79EUR210.
3
79
31/03/201931/03/2019
Distribution of Payment in Arrears

DISTR ARR

LN A Accrual Incoming Interest in Arrears60C10622000008Loan Sub-Acc. Interest Portions to be amortised
C
-
4.87
Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.210.
3
79EUR210.
3
79



Expand
titleGET /loans/gross-book-value-evidence (001-FK_LN-A-Consumer-Annuity)

The following table shows for deal "001-FK_LN-A-Consumer-Annuity" expected results relevant for the gross-book-value-evidence at different posting dates. 

For the explanation of the data fields see here.



postingDate13/09/201814/09/201830/09/201831/12/201802/01/201931/01/201920/03/201931/03/2019
companyId11111111gaapIFRS9IFRS9IFRS9IFRS9IFRS9IFRS9IFRS9IFRS9
dealId001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity
gaapIFRS9IFRS9IFRS9IFRS9IFRS9IFRS9IFRS9IFRS9
currencyDeal EUREUREUREUREUREUREUREUR
contractualRemainingCapital0-33000-33000-30459.44-29621.53-29621.53-27936.25-27936.25
contractualRemainingCapitalBal0-33000-33000-30459.44-29621.53-29621.53-27936.25-27936.25
dailyPayableNominal00000000
dailyPayableNominalBal00000000
dailyPayableInterest00000000
dailyPayableInterestBal00000000
dailyPayableCharge 00000000
dailyPayableChargeBal00000000
accruedInterestLinearInArrears00112.93175.90177.4113.53173.28
accruedInterestLinearInArrearsBal00112.93175.90177.4113.53173.28
effectiveInterestRate7.67253410367.67253410367.67253410367.67253410367.67253410367.67253410367.67253410367.6725341036
amortisedCost0-33000-33000-30459.44-29621.53-29621.53-27936.25-27936.25
amortisedCostBal0-33000-33000-30459.44-29621.53-29621.53-27936.25-27936.25
accruedChargesInAdvance00000000
accruedChargesInAdvanceBal00000000
accruedChargesInArrears00000000
accruedChargesInArrearsBal00000000
accruedPremiumDiscount00000000
accruedPremiumDiscountBal00000000
interestSmoothing00-1.762.962.816.55-10.02-4.87
interestSmoothingBal00-1.762.962.816.55-10.02-4.87
fairValueDcf033002.0333113.5930642.4829628.4530247.328440.5928495.91
fairValueDcfBal033002.0333113.5930642.4829628.4530247.328440.5928495.91
fairValueDcfConstantCreditSpread033002.0333113.5930642.4829628.4530247.328440.5928495.91
fairValueDcfConstantCreditSpreadBal033002.0333113.5930642.4829628.4530247.328440.5928495.91
stageShortNameHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHY
stageDescriptionLow credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)
eclAmountBal-247.45-247.5-248.33-229.79-222.18-223.54-210.3-210.79
unwinding00000000
unwindingBal00000000



...

Expand
titleGET /loans/accounting-transaction-related-accounting-ratios (001-FK_LN-A-Consumer-Annuity)

The following table shows for a

  • specific tenant (companyId) and for
  • deal (dealId) "001-FK_LN-A-Consumer-Annuity"
accounting transactions considering IFRS accounting rules
  • and for 
  • GAAP (gaap) "IFRS"

accounting transactions at various posting dates (postingDate)

For the explanation of the data fields see here.



postingDate accountingTransactionmeasureOrRatioDescriptionsignOfMeasureOrRatioamountAccountingRatiocurrencyTransactionamountAccountingRatioBalbankClientcustomerTypeproductaccountingCategoryimpairmentStageimpairmentType
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+812.8EUR812.80Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+812.8EUR812.80Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+820.91EUR820.910Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+820.91EUR820.910Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+906.85EUR906.850Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+906.85EUR906.850Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+812.8EUR812.80Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+812.8EUR812.80Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+820.91EUR820.910Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+820.91EUR820.910Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+906.85EUR906.850Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+906.85EUR906.850Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.790Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.790Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.330Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.330Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+119.99EUR119.990Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+119.99EUR119.990Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+205.93EUR205.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+205.93EUR205.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+214.04EUR214.040Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+214.04EUR214.040Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+119.99EUR119.990Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+119.99EUR119.990Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+205.93EUR205.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+205.93EUR205.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+214.04EUR214.040Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+214.04EUR214.040Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Real RepaymentCapital amount+837.91EUR837.910Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Real RepaymentCapital amount+837.91EUR837.910Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Repayment ContractualCapital amount+837.91EUR837.910Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Repayment ContractualCapital amount+837.91EUR837.910Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.180Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.180Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.790Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.790Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears ContractualCapital amount+188.93EUR188.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears ContractualCapital amount+188.93EUR188.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+188.93EUR188.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+188.93EUR188.930Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.180Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.180Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.540Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.540Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+842.18EUR842.180Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+842.18EUR842.180Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+843.1EUR843.10Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+843.1EUR843.10Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+842.18EUR842.180Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+842.18EUR842.180Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+843.1EUR843.10Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+843.1EUR843.10Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.30Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.30Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.540Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.540Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+183.74EUR183.740Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+183.74EUR183.740Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+184.66EUR184.660Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+184.66EUR184.660Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+183.74EUR183.740Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+183.74EUR183.740Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+184.66EUR184.660Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+184.66EUR184.660Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+173.28EUR173.280Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+173.28EUR173.280Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.870Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.870Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+210.3EUR210.30Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+210.3EUR210.30Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.79EUR210.790Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.79EUR210.790Private Customer
Ratenkredit
your product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)